Overview

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the long-term safety of asoprisnil in women with abnormal uterine bleeding associated with uterine fibroids.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott